The ratio of membrane-bound form Flt-1 mRNA to VEGF mRNA correlates with tumor angiogenesis and prognosis in non-small cell lung cancer

Cancer Letters
Kazumasa TakenakaFumihiro Tanaka

Abstract

Fms-like tyrosine kinase 1 (Flt-1), a receptor for vascular endothelial growth factor (VEGF), have two isoforms: membrane-bound form (mFlt-1) and soluble form. In the present study, we quantitatively evaluated expression level of mFlt-1 mRNA and VEGF mRNA in non-small cell lung cancer, and demonstrated the clinical significance of the ratio of mFlt-1 mRNA to VEGF mRNA (mFlt-1/VEGF). High mFlt-1/VEGF tumor showed a significantly lower microvessel density (P=0.004), and patients with high mFlt-1/VEGF tumor had a significantly favorable survival (P=0.037). Thus, the ratio of mFlt-1 mRNA to VEGF mRNA was inversely correlated with tumor angiogenesis, and was a significant prognostic factor.

References

Sep 30, 1992·Biochemical and Biophysical Research Communications·B I TermanP Böhlen
Jan 3, 1990·Journal of the National Cancer Institute·J Folkman
Nov 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R L Kendall, K A Thomas
Dec 1, 1995·American Journal of Respiratory and Critical Care Medicine·A YuanK T Luh
Apr 1, 1996·The Journal of Pathology·P KumarC Bernabeu
Feb 1, 1997·Endocrine Reviews·N Ferrara, T Davis-Smyth
Feb 20, 1997·International Journal of Cancer. Journal International Du Cancer·M VolmJ Mattern
May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·G SiemeisterG Martiny-Baron
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·S HiratsukaM Shibuya
Jun 20, 2002·Journal of the National Cancer Institute·Lynn HlatkyJudah Folkman
Jul 16, 2003·Cold Spring Harbor Symposia on Quantitative Biology·N W GaleG D Yancopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.